| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.01B | 82.88B | 76.89B | 77.96B | 66.85B | 59.98B |
| Gross Profit | 15.73B | 19.88B | 15.46B | 18.53B | 16.09B | 15.47B |
| EBITDA | 7.90B | 8.22B | 5.63B | 8.57B | 7.99B | 8.17B |
| Net Income | 820.00M | 2.23B | 1.51B | 3.15B | 4.66B | 3.82B |
Balance Sheet | ||||||
| Total Assets | 77.57B | 76.28B | 76.41B | 70.66B | 66.87B | 56.87B |
| Cash, Cash Equivalents and Short-Term Investments | 17.23B | 17.12B | 18.70B | 17.69B | 13.82B | 15.46B |
| Total Debt | 10.22B | 10.51B | 13.59B | 11.18B | 7.77B | 9.15B |
| Total Liabilities | 26.15B | 24.25B | 26.02B | 23.43B | 22.54B | 20.66B |
| Stockholders Equity | 51.33B | 51.94B | 50.30B | 47.16B | 44.27B | 36.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.76B | 906.00M | 2.67B | -1.06B | 1.18B |
| Operating Cash Flow | 0.00 | 7.24B | 4.82B | 7.31B | 3.68B | 5.14B |
| Investing Cash Flow | 0.00 | -4.08B | -5.13B | -5.86B | -5.97B | -4.62B |
| Financing Cash Flow | 0.00 | -4.62B | -260.00M | 1.53B | 171.00M | 1.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥433.81B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥703.28B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥70.75B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
74 Outperform | ¥6.91T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
67 Neutral | ¥4.04T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥158.77B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |